Related references
Note: Only part of the references are listed.Statin Use and Risk of Cognitive Decline in the ADNI Cohort
Emily C. Kemp et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2020)
Adherence to statin therapy and the incidence of ischemic stroke in patients with diabetes
Maarit Jaana Korhonen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Dipeptidyl peptidase-4 inhibitor use is not associated with elevated risk of severe joint pain in patients with type 2 diabetes: a population-based cohort study
Wen-Hsuan Hou et al.
PAIN (2016)
Statins for the prevention of dementia
Bernadette McGuinness et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
The Propensity Score
Jason S. Haukoos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study
Shu-Chen Kuo et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Nationwide Population Science Lessons From the Taiwan National Health Insurance Research Database
Ann W. Hsing et al.
JAMA INTERNAL MEDICINE (2015)
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis
Ana Filipa Macedo et al.
BMC MEDICINE (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Predictors of medication adherence in patients with type 2 diabetes mellitus
Suellen M. Curkendall et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Statins in the prevention of dementia and Alzheimer's disease: A meta-analysis of observational studies and an assessment of confounding
William B. Wong et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Why is greater medication adherence associated with better outcomes
Arthur Hartz et al.
EMERGING THEMES IN EPIDEMIOLOGY (2013)
Results of a Retrospective Database Analysis of Adherence to Statin Therapy and Risk of Nonfatal Ischemic Heart Disease in Daily Clinical Practice in Italy
Giovanni Corrao et al.
CLINICAL THERAPEUTICS (2010)
Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials
Liam Smeeth et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study
M. D. M. Haag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study
C. Cramer et al.
NEUROLOGY (2008)
Association of statin use with cognitive decline in elderly African Americans
S. J. Szwast et al.
NEUROLOGY (2007)
Factors related to adherence to statin therapy
Brandy McGinnis et al.
ANNALS OF PHARMACOTHERAPY (2007)
Do statins reduce risk of incident dementia and Alzheimer disease? The cache county study
PP Zandi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Association between statin use and Alzheimer's disease
E Zamrini et al.
NEUROEPIDEMIOLOGY (2004)
Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia:: data from the Canadian Study of Health and Aging
GYR Hsiung et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Role of the low-density lipoprotein receptor-related protein in β-amyloid metabolism and Alzheimer disease
BT Hyman et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
